These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Role of chlorpromazine in maintaining timing behavior in chronic schizophrenics. Angle HV Psychopharmacologia; 1973 Jan; 28(2):185-94. PubMed ID: 4694626 [No Abstract] [Full Text] [Related]
5. Urinary excretion of catecholamines and their metabolites in chronic schizophrenics treated with oxypertine and chlorpromazine. Kiriike N; Uete T; Motomura K; Enomoto M; Murata K Biol Psychiatry; 1984 Mar; 19(3):417-22. PubMed ID: 6144330 [No Abstract] [Full Text] [Related]
6. Temporal changes in handwriting size, level of premorbid social functioning and intellectural level during treatment in acute schizophrenics. Downing RW; Ebert JN; Boruchow JK; Valentine JH J Nerv Ment Dis; 1966 Jun; 142(6):526-33. PubMed ID: 5920205 [No Abstract] [Full Text] [Related]
7. Phenothiazine effects on psychological and psychophysiological dysfunction in chronic schizophrenics. Spohn HE; Lacoursiere RB; Thompson K; Coyne L Arch Gen Psychiatry; 1977 Jun; 34(6):633-44. PubMed ID: 326215 [TBL] [Abstract][Full Text] [Related]
8. A 12-year follow-up study of chronic schizophrenics. Gardos G; Cole JO; LaBrie RA Hosp Community Psychiatry; 1982 Dec; 33(12):983-4. PubMed ID: 7152500 [No Abstract] [Full Text] [Related]
9. Laterality, attention and rate effects in the auditory temporal discrimination of chronic schizophrenics: the effect of treatment with chlorpromazine. Hammond NV; Gruzelier JH Q J Exp Psychol; 1978 Feb; 30(1):91-103. PubMed ID: 345319 [No Abstract] [Full Text] [Related]
11. A double blind controlled study of ECT vs chlorpromazine in schizophrenia. Bagadia VN; Abhyankar RR; Doshi J; Pradhan PV; Shah LP J Assoc Physicians India; 1983 Oct; 31(10):637-40. PubMed ID: 6671932 [No Abstract] [Full Text] [Related]
12. Plasma-level studies of chlorpromazine following the administration of chlorpromazine hydrochloride and chlorpromazine embonate in chronic schizophrenics. Cooper SF; Albert JM; Hillel J; Caille G Curr Ther Res Clin Exp; 1973 Feb; 15(2):73-7. PubMed ID: 4632509 [No Abstract] [Full Text] [Related]
13. A double-blind comparison of mesoridazine and chlorpromazine in chronic schizophrenics. Freeman H Dis Nerv Syst; 1973; 34(6):289-93. PubMed ID: 4782285 [No Abstract] [Full Text] [Related]
14. The evaluation of chlorpromazine therapy in chronic schizophrenic women. A replicated experiment. Ragland R; Clark ML; Ray TS; Paredes A; Costiloe JP; Segal B; Wolf S J Chronic Dis; 1968 Oct; 21(6):445-60. PubMed ID: 4879902 [No Abstract] [Full Text] [Related]
15. Methodological issues in psychopharmacological research. Davis JM; Hurt SW Am J Orthopsychiatry; 1977 Jul; 47(3):523-36. PubMed ID: 888926 [No Abstract] [Full Text] [Related]
16. Effect of prolonged chlorpromazine administration on the sleep of chronic schizophrenics. Kaplan J; Dawson S; Vaughan T; Green R; Wyatt RJ Arch Gen Psychiatry; 1974 Jul; 31(1):62-6. PubMed ID: 4365280 [No Abstract] [Full Text] [Related]
17. Premorbid asocial adjustment and response to phenothiazine treatment among schizophrenic inpatients. Klein DF; Rosen B Arch Gen Psychiatry; 1973 Oct; 29(4):480-5. PubMed ID: 4583948 [No Abstract] [Full Text] [Related]
18. Mesoridazine versus chlorpromazine in acute schizophrenia: a double-blind investigation. Hamid TA; Wertz WJ Am J Psychiatry; 1973 Jun; 130(6):689-92. PubMed ID: 4573820 [No Abstract] [Full Text] [Related]
19. Perception of relative size of maternal figure and subjects figure by schizophrenics and normals. Hamersma RJ; Papson B Percept Mot Skills; 1973 Apr; 36(2):487-93. PubMed ID: 4690738 [No Abstract] [Full Text] [Related]